Vancomycin Iv Injection 1G (1 Box = 1 Injection)

Name: Vancomycin Iv Injection 1G (1 Box = 1 Injection)
Brand: ABBOT LABORATORIES (PAK) LTD
Price: 2439.01

Brand : abbot laboratories (pak) ltd

Rs. 2,439.01

Rs. 2,567.38

|

QUICK DELIVERY

Vancomycin Iv Specification

Requires Prescription (YES/NO)

Yes

Generics

Vancomycin HCI

Used For

Bacterial Infection

How it works

The bactericidal action of Vancomycin results primarily from inhibition of cell-wall biosynthesis. In addition, Vancomycin alters bacterial-cell membrane permeability and RNA synthesis. There is no cross-resistance between Vancomycin and other antibiotics.

Vancomycin Iv Usage And Safety

Dosage

Vancomycin HCI

Side Effects

Infusion related events , nephrotoxicity , ototoxicity , neutropenia , nausea , chills , fever , rashes , eosinophillia , phlebitis , decreased BP , dyspnoea , stridor , pruritis , mucosal inflammation , severe pain at inj site.

Drug Interactions

Neurotoxic , ototoxic or nephrotoxic drugs , anesthetics , PPIs , antimotility agents.

Indication

Serious or severe infections caused by susceptible strains of methicillin-resistant (beta-lactam-resistant) staphylococci, pencillin-alergic patients. For infections caused by vancomycin susceptible organisms for initial therapy, when methicillin resistant staphylococci are suspected. In the treatment of staphylococcal endocarditis, infections due to staphylococci, including septicemia, bone infections, lower respiratory tract infections, and skin & skin structure infections.

When not to Use

Vancomycin HCI is contraindicated in patients with known hypersensitivity to this antibiotic.

Vancomycin Iv Precautions

Precaution

In order to minimise the risk of nephrotoxicity when treating patients with underlying renal dysfunction or patients receiving concomitant therapy with an aminoglycoside. Serial monitoring or renal function should be performed and particular care should be taken in following appropriate dosing schedules.

Vancomycin Iv Warnings

Warning 1

Rapid bolus administration (e.g. Over several minutes) may be associated with exaggerated hypotension and rarelycardiac a rest.

Warning 2

Vancomycin HCI should be administered in a diluted solution over a period of not less than 60 minutes to avoid rapid-infusion-related reactions. Stopping the infusion usually results in prompt cessation of there reactions.

Warning 3

Ototoxicity has occurred in patients receiving Vancomycin HCI. It may be transient or permanent. It has been reported mostly in patients who have given excessive doses. who have an underfying hearing loss, or who are receiving concomitant therapy with another ototoxic agent,such as an aminoglycoside .

Download the Dvago App